Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study
- PMID: 36195915
- PMCID: PMC9533507
- DOI: 10.1186/s12967-022-03655-6
Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study
Keywords: Hypoxia; Sepsis; miR-210.
Conflict of interest statement
S.Y.C. has served as a consultant for Acceleron Pharma and United Therapeutics. S.Y.C. is a director, officer, and shareholder in Synhale Therapeutics. S.Y.C. has held research grants from Actelion, Bayer, and Pfizer. S.Y.C. has filed patent applications regarding the targeting of metabolism in pulmonary hypertension. The other authors declare no competing interests.
Figures

References
-
- Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020 Aug 1;202(3):361–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical